Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study.

  • Etude concernée: IFCT-2105
  • Auteurs / Authors: Girard N, Guisier F, Swalduz A, Van Hulst S, Pichon E, Lavaud P, Greillier L, Tiotiu A, Madroszyk A, Bylicki O, Canellas A, Belmont L, Zysman M, Hauss PA, Godbert B, Audigier-Valette C, Lebreton C, Morin F, Westeel V.
  • Journal / Conference: ESMO Open
  • Année / Year: 2024
  • PMID: 39608302
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/39608302/
  • PDF: 1-s2.0-S2059702924017381-main.pdf